Active

    Ujin Pharma Limited

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Ujin Pharma Limited IPO Details

    Listing Date

    -

    Bid Price

    ₹0 - ₹0

    Lot Size

    0 Shares

    Minimum Investment

    ₹

    Issue Size

    ₹0 Cr

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    -

    tick

    Offer End Date

    -

    tick

    Allotment Date

    -

    tick

    Refund Initiation

    -

    tick

    Demat Transfer

    -

    tick

    Listing Date

    -

    Ujin Pharma Limited Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 0% 0%
    Public Group 100% 100%

    Ujin Pharma Limited IPO Reservation

    QIB Shares Offered 0 (0%)
    NII (HNI) Shares Offered 0 (0%)
    Retail Shares Offered 0 (0%)
    Anchor Investor Shares Offered 0 (0%)
    Total Shares Offered 0
    Total Shares With Anchor Investor 0

    Ujin Pharma Limited IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) [-] [-] ₹[-]
    Retail (Max) [-] [-] ₹[-]
    S HNI (Min) [-] [-] ₹[-]
    S HNI (Max) [-] [-] ₹[-]
    B HNI (MIN) [-] [-] ₹[-]

    Ujin Pharma Limited IPO registrar

    KFin Technologies Ltd
    Phone Number +91 40 67162222/ 1800 3094001
    Email Id ujinpharma.ipo@kfintech.com
    Website www.kfintech.com

    Ujin Pharma Limited IPO Lead Manager

    1. SMC Capitals Limited

    2. Marwadi Chandarana Intermediaries Brokers Pvt Ltd

    Strength of Ujin Pharma Limited

    • Established sourcing network and supply chain capabilities supporting our distribution operations.
    • Diversified product portfolio catering to multiple end-use industries.
    • Established customer relationships across domestic and select international markets.
    • Expansion into value-added chemical processing through our Subsidiary, SSOPL.
    • Warehousing and logistics capabilities supporting product availability and timely supply.
    • Growth in scale of operations and improvement in operating profitability.
    • Strategic expansion into complementary chemical segments.
    • Experienced Promoters and senior management team.

    Risks Involved

    • The company derives a substantial portion of its revenue from operations from the company distribution business. Revenue from its distribution business aggregated to Rs.14,441.28 million, Rs.16,220.00 million, Rs.14,787.89 million and Rs.14,257.61 million for the nine-month period ended December 31, 2025 and Fiscals 2025, 2024 and 2023, respectively, representing 95.65%, 99.82%, 100.00% and 100.00% of sale of products, classified by business vertical, for the respective periods. Any adverse developments affecting its distribution business, including reduction in demand, pricing pressures, supply disruptions, inability to source products on commercially acceptable terms or inability to maintain supplier and customer relationships, may materially and adversely affect the company business, financial condition, results of operations, cash flows and prospects.
    • The company's import chemical products from international markets, with purchases from international suppliers aggregating to Rs.3,976.60 million, Rs.4,140.12 million, Rs.4,238.33 million and Rs.4,625.81 million for the nine-month period ended December 31, 2025 and Fiscals 2025, 2024 and 2023, respectively, representing 26.56%, 26.84%, 30.14% and 33.61% of its total purchases for the respective periods. Any disruption in imports, including due to geopolitical tensions involving the Middle East, the United States and Iran, risks relating to the Strait of Hormuz, the Russia-Ukraine conflict, sanctions, shipping disruptions, increase in freight costs, foreign exchange volatility or adverse changes in import regulations, may materially and adversely affect the company business, financial condition, results of operations, cash flows and prospects.
    • The company's top 10 suppliers contributed Rs.6,933.09 million, Rs.7,418.98 million, Rs.5,670.21 million and Rs.6,237.05 million to its total purchases for the nine-month period ended December 31, 2025 and Fiscals 2025, 2024 and 2023, respectively, representing 46.13%, 48.10%, 40.32% and 45.32% of the company total purchases for the respective periods. Any inability to procure products from its significant suppliers on commercially acceptable terms, or at all, may materially and adversely affect its business, financial condition, results of operations, cash flows and prospects.
    • A substantial portion of the company revenue from sale of products is generated through indirect sales to thirdparty traders and distributors. Revenue from indirect sales aggregated to Rs.10,191.50 million, Rs.10,974.48 million, Rs.10,892.85 million and Rs.8,911.61 million for the nine-month period ended December 31, 2025 and Fiscals 2025, 2024 and 2023, respectively, representing 67.50%, 67.54%, 73.66% and 62.50% of the company revenue from sale of products for the respective periods. Any inability to maintain relationships with such third-party traders and distributors, or any inability to accurately determine the end-use industry of products sold through them, may adversely affect its business, financial condition, results of operations, cash flows and prospects.
    • The company derives a substantial portion of its revenue sale of products from sales in India, and within India, a significant portion of the company domestic revenue is derived from customers located in Maharashtra and Gujarat. Revenue from India aggregated to Rs.12890.51 million, Rs.13884.16 million, Rs.12719.32 million and Rs.11147.57 million for the nine-month period ended December 31, 2025 and Fiscals 2025, 2024 and 2023, respectively, representing 85.38%, 85.45%, 82.36% and 78.19% of the company revenue from sale of products for the respective periods. Any adverse developments affecting demand, pricing, logistics, regulatory conditions or customer requirements in India, particularly in Maharashtra and Gujarat, may materially and adversely affect its business, financial condition, results of operations, cash flows and prospects.
    • The company does not have long-term agreements with its customers and the company sales are primarily based on purchase orders placed by customers from time to time. Further, its top 10 customers contributed Rs.4,927.98 million, Rs.5,006.30 million, Rs.4,775.41 million and Rs.3,855.88 million to the company revenue from Sale of Products for the nine-month period ended December 31, 2025 and Fiscals 2025, 2024 and 2023, respectively, representing 32.64%, 30.81%, 32.29% and 27.04% of its revenue from Sale of Products for the respective periods. Any reduction, delay or cessation of orders from, or loss of, the company significant customers may materially and adversely affect its business, financial condition, results of operations, cash flows and prospects.
    • A significant portion of the company revenue from sale of products is derived from Methanol and Toluene. These products together contributed Rs.5,257.25 million, Rs.4,761.22 million, Rs.4,322.82 million and Rs.4,924.34 million, representing 34.82%, 29.30%, 29.24% and 34.53% of its revenue from sale of products for the nine-month period ended December 31, 2025 and Fiscals 2025, 2024 and 2023, respectively. Any reduction in demand for, or margins from, these products may adversely affect the company business, results of operations and financial condition.
    • The company's strategy to transition from a primarily distribution-led business to a more integrated manufacturing and value-added chemical processing business is dependent on the successful integration and scaling of SSOPL and the proposed investments in its Associate Companies i.e. Altra Agro-Chem Private Limited and Altra Pharma-Chem Private Limited. Any inability to successfully implement this strategy may adversely affect its business, financial condition, results of operations, cash flows and prospects.
    • The Company has in the nine-month period ended December 31, 2025 and Fiscals 2025, 2024 and 2023, entered into certain related party transactions with related parties, in the ordinary course of its business and the company cannot assure you that such transactions will not adversely affect its financial condition and results of operations.
    • The company has incurred indebtedness and are subject to certain obligations and restrictive covenants under its financing arrangements. Any inability to comply with such obligations or covenants may adversely affect the company business, financial condition, results of operations and cash flows.

    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    CORE4 ENGINEERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Oct 2026 - 10th Oct 2026
    Price Range
    ₹88.0 - 93.0
    IPO Size
    ₹54,82,00,000
    • All
    • MainBoard
    • SME
    Bidding Period
    26th Oct 2026 - 10th Oct 2026
    Price Range
    ₹1585.0 - 1665.0
    IPO Size
    ₹12,00,00,00,000
    BLS Polymers Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹142.0 - 150.0
    IPO Size
    ₹2,55,00,00,128
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹313.0 - 330.0
    IPO Size
    ₹6,67,53,00,352
    Wiscon Industries Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Oct 2026 - 10th Oct 2026
    Price Range
    ₹194.0 - 204.0
    IPO Size
    ₹1,10,00,00,000
    Carver Roboweld Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Oct 2026 - 10th Oct 2026
    Price Range
    ₹76.0 - 80.0
    IPO Size
    ₹0
    Bidding Period
    29th Oct 2026 - 11th Nov 2026
    Price Range
    ₹78.0 - 82.0
    IPO Size
    ₹1,83,05,99,936
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AGS Health Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AITMC Ventures Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    JIO PLATFORMS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹1065.0 - 1119.0
    IPO Size
    ₹3,02,13,00,03,968
    PARAS HEALTHCARE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Oct 2026 - 10th Oct 2026
    Price Range
    ₹660.0 - 693.0
    IPO Size
    ₹14,49,99,99,744
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹327.0 - 344.0
    IPO Size
    ₹4,75,48,00,128
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹558.0 - 586.0
    IPO Size
    ₹25,33,80,99,712
    SHELLZ INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹170.0 - 179.0
    IPO Size
    ₹59,97,00,032
    TONBO IMAGING INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹665.0 - 700.0
    IPO Size
    ₹8,52,17,99,680
    Bidding Period
    15th Oct 2026 - 10th Oct 2026
    Price Range
    ₹143.0 - 151.0
    IPO Size
    ₹50,12,33,00,864
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹275.0 - 289.0
    IPO Size
    ₹7,02,00,00,256
    Bidding Period
    14th Oct 2026 - 10th Oct 2026
    Price Range
    ₹105.0 - 112.0
    IPO Size
    ₹1,16,04,99,968
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹258.0 - 271.0
    IPO Size
    ₹7,12,12,99,968
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    13th Oct 2026 - 10th Oct 2026
    Price Range
    ₹51.0 - 54.0
    IPO Size
    ₹42,10,00,000
    Bidding Period
    5th Oct 2026 - 10th Oct 2026
    Price Range
    ₹77.0 - 82.0
    IPO Size
    ₹34,99,00,032
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹119.0 - 127.0
    IPO Size
    ₹81,79,00,032
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹186.0 - 196.0
    IPO Size
    ₹1,21,68,99,968
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹37,86,00,000
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹208.0 - 220.0
    IPO Size
    ₹1,78,00,00,000
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    28th Sep 2026 - 10th Oct 2026
    Price Range
    ₹50.0 - 53.0
    IPO Size
    ₹31,80,00,000
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹67.0 - 67.0
    IPO Size
    ₹23,45,00,000
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹55.0 - 55.0
    IPO Size
    ₹21,78,00,000
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Sep 2026 - 10th Oct 2026
    Price Range
    ₹112.0 - 118.0
    IPO Size
    ₹38,12,00,000
    • All
    • MainBoard
    • SME
    Issue Prize
    1785.00
    Listing Day Close
    1818.00(1.85%)
    LAPL AUTOMOTIVE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    94.00
    Listing Day Close
    128.29(36.17%)
    FUSION CX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    289.00
    Listing Day Close
    289.75(0.35%)
    HD FIRE PROTECT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    271.00
    Listing Day Close
    307.20(13.28%)
    Issue Prize
    112.00
    Listing Day Close
    113.70(1.79%)
    VAIBHAV VYAPAAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    54.00
    Listing Day Close
    53.05(-1.85%)
    Issue Prize
    82.00
    Listing Day Close
    76.00(-7.32%)
    PARAMOUNT SYNTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    127.00
    Listing Day Close
    109.25(-14.17%)
    Issue Prize
    196.00
    Listing Day Close
    232.05(18.37%)
    TNA SOLUTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    70.00
    Listing Day Close
    58.80(-15.71%)
    VISHAL NIRMITI LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    220.00
    Listing Day Close
    204.25(-7.27%)
    SHREE TNB POLYMERS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    53.00
    Listing Day Close
    57.00(7.55%)
    SJP ULTRASONICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    67.00
    Listing Day Close
    73.01(8.96%)
    Issue Prize
    55.00
    Listing Day Close
    99.18(80.00%)
    EVENTIONS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    118.00
    Listing Day Close
    105.45(-11.02%)
    Issue Prize
    85.00
    Listing Day Close
    119.70(41.18%)
    Issue Prize
    75.00
    Listing Day Close
    84.15(12.00%)
    OMARA VENTURES INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    311.00
    Listing Day Close
    319.05(2.57%)
    Issue Prize
    72.00
    Listing Day Close
    68.75(-4.17%)
    GREEN ASIA IMPEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    89.00
    Listing Day Close
    84.55(-4.49%)

    Frequently Asked Questions

    What is Ujin Pharma Limited IPO?

    Ujin Pharma Limited IPO is a IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. KFin Technologies Ltd is the registrar for the IPO. The shares are proposed to be listed on .

    When Ujin Pharma Limited IPO will open?

    The Ujin Pharma Limited IPO opens on [-] and closes on [-].

    What is the lot size of Ujin Pharma Limited?

    Ujin Pharma Limited lot size is [-] shares, and the minimum amount required is ₹[-].

    How to apply for Ujin Pharma Limited IPO?

    You can apply in Ujin Pharma Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Ujin Pharma Limited IPO allotment?

    The finalization of Basis of Allotment for Ujin Pharma Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

    When is Ujin Pharma Limited IPO listing date?

    The Ujin Pharma Limited listing date is [-].

    Who is the registrar of Ujin Pharma Limited IPO?

    The registrar of Ujin Pharma Limited IPO is KFin Technologies Ltd

    Which company is the book-running lead manager of the IPO?

    SMC Capitals Limited,Marwadi Chandarana Intermediaries Brokers Pvt Ltd will be the book-running lead manager of this IPO.

    What is the fresh issue of Ujin Pharma Limited IPO?

    The fresh issue size is ₹[-] Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Ujin Pharma Limited?

    Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

    How can I approve the UPI mandate request for Ujin Pharma Limited IPO?

    To apply for Ujin Pharma Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Ujin Pharma Limited?

    The price of each Ujin Pharma Limited share will be ranging in between ₹[-] to ₹[-] per share.

    What is the cut-off time for the UPI mandate for Ujin Pharma Limited IPO?

    The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |